^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ampulla of Vater Carcinoma |
| Drug: | Avastin (bevacizumab) (VEGF-A inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/27/2023
Excerpt:
Ampullary Adenocarcinoma….Poor PS:...Intestinal Type, For select patients with ECOG 2 consider multi-agent regimens:...5-FU + leucovorin ± bevacizumab.
Secondary therapy:
5-fluorouracil + leucovorin calcium
